C7R-GD2.CAR T Cells for Patients With GD2-expressing Brain Tumors (GAIL-B)

Clinical trial NCT04099797 · RECRUITING

Trial details

NCT number: NCT04099797
Sponsor: Baylor College of Medicine
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Diffuse Intrinsic Pontine Glioma High Grade Glioma Embryonal Tumor Ependymal Tumor

Start date: 2020-02-03
Primary completion: 2027-02-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.